InMed Pharmaceuticals Inc (INM)

[Stevemin]

Just received an alert from the USPTO about Inmed's EB patent application which states the following:

Title: USE OF TOPICAL FORMULATIONS OF CANNABINOIDS IN THE TREATMENT OF EPIDERMOLYSIS BULLOSA AND RELATED CONNECTIVE TISSUE DISORDERS
Application: 16098324

New status: Non Final Action Counted, Not Yet Mailed
Date of new status: 12/07/2020

The new status reflects the last status in Public Patent Application Information Retrieval (PAIR) as of 11:59 p.m. ET on
the date noted above.

For those who aren't familiar with the process, a "Non-Final Office Action" always contains a rejection of or objection to some part of the patent application. Inmed has an opportunity to respond to a this by doing one or both of the following: (1) arguing that the examiner is incorrect; and (2) amending the claims and/or specification of the application to overcome the examiner’s rejections. They could also speak with the examiner on the telephone or meet with the examiner in person in an attempt to reach an understanding and obtain allowance of the patent application.

This is a normal part of the process and does not necessarily indicate that the patent application will not be granted as a patent, just wanted to pass along the info.